<?xml version="1.0" encoding="UTF-8"?>

<Bundle xmlns="http://hl7.org/fhir">
  <id value="f8ab1cce-d654-4e2e-b9b6-bee927a3e0e3"/>
  <meta>
    <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi"/>
  </meta>
  <identifier>
    <system value="https://www.gravitatehealth.eu/sid/doc"/>
    <value value="EU/1/16/1157/003"/>
  </identifier>
  <type value="document"/>
  <timestamp value="2022-12-19T16:57:21Z"/>
  <entry>
    <fullUrl value="Composition/69be4041-e893-4621-b41b-4f12236e30ed"/>
    <resource>
      <Composition>
        <id value="69be4041-e893-4621-b41b-4f12236e30ed"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Composition</b><a name="69be4041-e893-4621-b41b-4f12236e30ed"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Composition &quot;69be4041-e893-4621-b41b-4f12236e30ed&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-Composition-uv-epi.html">Composition (ePI)</a></p></div><p><b>identifier</b>: id:Â 0d69fdcb-33cf-407f-8209-a6529856ab4f</p><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000155538)</span></p><p><b>date</b>: 2022-02-16 13:28:17+0000</p><p><b>author</b>: <a href="#Organization_9986b39a-e820-49a9-9b65-de34d6079331">See above (Organization/9986b39a-e820-49a9-9b65-de34d6079331)</a></p><p><b>title</b>: TEST PURPOSES ONLY - adalimumab</p></div>
        </text>
        <identifier>
          <system value="https://spor.ema.europa.eu/rmswi/"/>
          <value value="0d69fdcb-33cf-407f-8209-a6529856ab4f"/>
        </identifier>
        <status value="final"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi/"/>
            <code value="100000155538"/>
          </coding>
          <text value="Package Leaflet"/>
        </type>
        <subject>
          <reference value="MedicinalProductDefinition/8e4f1fbf-70e9-470a-9694-e0168320b56c"/>
        </subject>
        <date value="2022-02-16T13:28:17Z"/>
        <author>
          <reference value="Organization/9986b39a-e820-49a9-9b65-de34d6079331"/>
        </author>
        <title value="TEST PURPOSES ONLY - adalimumab"/>
        <section>
          <title value="Product Information"/>
          <code>
            <text value="Product Info"/>
          </code>
          <entry>
            <reference value="Ingredient/f5eba89a-53bf-41cc-a00f-a81330062946"/>
          </entry>
          <entry>
            <reference value="Ingredient/34734d5b-c7cf-4a3e-bf87-1412db87476e"/>
          </entry>
          <entry>
            <reference value="Ingredient/06d11577-dc08-4fe4-b9f3-3b98f8e4159b"/>
          </entry>
          <entry>
            <reference value="AdministrableProductDefinition/88272368-f0bf-4222-aec0-4829b44b6d0b"/>
          </entry>
          <entry>
            <reference value="RegulatedAuthorization/36aab683-567b-42c5-a65c-b3c2749b4660"/>
          </entry>
          <entry>
            <reference value="Organization/9986b39a-e820-49a9-9b65-de34d6079331"/>
          </entry>
          <entry>
            <reference value="Organization/a86857b5-0210-4df3-b550-e326ab3e2101"/>
          </entry>
          <entry>
            <reference value="Organization/6f34afc3-66a7-4410-99ad-53604ea211f4"/>
          </entry>
          <entry>
            <reference value="Organization/dbeccd59-b7ba-4640-a617-ad9d910e71bf"/>
          </entry>
          <entry>
            <reference value="PackagedProductDefinition/560639ae-8c6a-4f98-9a5b-455534b1b16a"/>
          </entry>
          <entry>
            <reference value="MedicinalProductDefinition/8e4f1fbf-70e9-470a-9694-e0168320b56c"/>
          </entry>
          <entry>
            <reference value="ManufacturedItemDefinition/3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7"/>
          </entry>
        </section>
        <section>
          <title value="Narrative Text"/>
          <code>
            <text value="Narrative"/>
          </code>
          <section>
            <title value="B. Package Leaflet"/>
            <code>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi/"/>
                <code value="100000155538"/>
              </coding>
              <text value="B. PACKAGE LEAFLET"/>
            </code>
            <text>
              <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml">unavailable</div>
            </text>
            <emptyReason>
              <coding>
                <system value="http://terminology.hl7.org/CodeSystem/list-empty-reason"/>
                <code value="unavailable"/>
              </coding>
            </emptyReason>
            <section>
              <title value="Package leaflet: Information for the user"/>
              <code>
                <coding>
                  <system value="https://spor.ema.europa.eu/rmswi/"/>
                  <code value="100000155538"/>
                </coding>
                <text value="Package leaflet: Information for the user"/>
              </code>
              <text>
                <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><div xmlns="http://www.w3.org/1999/xhtml">PACKAGE LEAFLET: INFORMATION FOR THE USER Humalog Mix50 100 units/ml suspension for injection in cartridge insulin lispro Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.<ul><li>Keep this leaflet. You may need to read it again.</li><li>If you have any further questions, ask your doctor or pharmacist.</li><li>This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.</li><li>If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.</li></ul></div></div>
              </text>
            </section>
            <section>
              <title value="What is in this leaflet"/>
              <code>
                <coding>
                  <system value="https://spor.ema.europa.eu/rmswi/"/>
                  <code value="100000155538"/>
                </coding>
                <text value="What is in this leaflet"/>
              </code>
              <text>
                <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><div xmlns="http://www.w3.org/1999/xhtml">What in this leaflet<ol><li>What Humalog Mix50 is and what it is used for</li><li>What you need to know before you take Humalog Mix50</li><li>How to take Humalog Mix50</li><li>Possible side effects</li><li>How to store Humalog Mix50</li><li>Contents of the pack and other information</li></ol></div></div>
              </text>
            </section>
            <section>
              <title value="1. What adalimumab is and what it is used for"/>
              <code>
                <coding>
                  <system value="https://spor.ema.europa.eu/rmswi/"/>
                  <code value="100000155538"/>
                </coding>
                <text value="1. What adalimumab is and what it is used for"/>
              </code>
              <text>
                <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml">unavailable</div>
              </text>
              <emptyReason>
                <coding>
                  <system value="http://terminology.hl7.org/CodeSystem/list-empty-reason"/>
                  <code value="unavailable"/>
                </coding>
              </emptyReason>
            </section>
            <section>
              <title value="2. What you need to know before you take adalimumab"/>
              <code>
                <coding>
                  <system value="https://spor.ema.europa.eu/rmswi/"/>
                  <code value="100000155538"/>
                </coding>
                <text value="2. What you need to know before you take adalimumab"/>
              </code>
              <text>
                <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><b>2. What you need to know before you use Humalog Mix50</b> Do NOT use Humalog Mix50 if you</div></div>
              </text>
            </section>
            <section>
              <title value="3. How to take adalimumab"/>
              <code>
                <coding>
                  <system value="https://spor.ema.europa.eu/rmswi/"/>
                  <code value="100000155538"/>
                </coding>
                <text value="3. How to take adalimumab"/>
              </code>
              <text>
                <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><b>3. How to use Humalog Mix50</b> <b>The 3 ml cartridge is only for use in Lilly 3 ml pens. It is not for use in 1.5 ml pens.</b><p>Always use Humalog Mix50 exactly as your doctor has told you. You should check with your doctor if you are not sure. To prevent the possible transmission of disease, each cartridge must be used by you only, even if the needle on the delivery device is changed.</p></div></div>
              </text>
            </section>
            <section>
              <title value="4. Possible side effects"/>
              <code>
                <coding>
                  <system value="https://spor.ema.europa.eu/rmswi/"/>
                  <code value="100000155538"/>
                </coding>
                <text value="4. Possible side effects"/>
              </code>
              <text>
                <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p><b>4. Possible side effects</b></p><p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p></div></div>
              </text>
            </section>
            <section>
              <title value="5. How to store adalimumab"/>
              <code>
                <coding>
                  <system value="https://spor.ema.europa.eu/rmswi/"/>
                  <code value="100000155538"/>
                </coding>
                <text value="5. How to store adalimumab"/>
              </code>
              <text>
                <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the carton and on the blister after EXP. The expiry date refers to the last day of that month.</p><p>Do not store above 30Â°C.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away of medicines you no longer use. These measures will help protect the environment.</p></div></div>
              </text>
            </section>
            <section>
              <title value="6. Contents of the pack and other information"/>
              <code>
                <coding>
                  <system value="https://spor.ema.europa.eu/rmswi/"/>
                  <code value="100000155538"/>
                </coding>
                <text value="6. Contents of the pack and other information"/>
              </code>
              <text>
                <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><div xmlns="http://www.w3.org/1999/xhtml"><b>6. Contents of the pack and other information</b> <b>What Humalog Mix50 100 units/ml suspension for injection in cartridge contains</b><p>The active substance is insulin lispro. Insulin lispro is made in the laboratory by a ârecombinant DNA technologyâ process. It is a changed form of human insulin and so is different from other human and animal insulins. Insulin lispro is closely related to human insulin which is a natural hormone made by the pancreas. The other ingredients are protamine sulphate, m-cresol, phenol, glycerol, dibasic sodium phosphate 7H2O, zinc oxide and water for injection. Sodium hydroxide or hydrochloric acid may have been used to adjust the acidity.</p></div></div>
              </text>
            </section>
          </section>
        </section>
      </Composition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="Ingredient/f5eba89a-53bf-41cc-a00f-a81330062946"/>
    <resource>
      <Ingredient>
        <id value="f5eba89a-53bf-41cc-a00f-a81330062946"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Ingredient</b><a name="f5eba89a-53bf-41cc-a00f-a81330062946"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient &quot;f5eba89a-53bf-41cc-a00f-a81330062946&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id:Â 2ZM8CX04RZÂ (use:Â OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href="#ManufacturedItemDefinition_3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7">See above (ManufacturedItemDefinition/3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7)</a></p><p><b>role</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#72072)</span></p><h3>Manufacturers</h3><table class="grid"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href="#Organization_9986b39a-e820-49a9-9b65-de34d6079331">See above (Organization/9986b39a-e820-49a9-9b65-de34d6079331)</a></td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td>-</td><td><b>Concept</b></td></tr><tr><td>*</td><td>Insulin glargine <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.0.0/CodeSystem-UNII.html">Unique Ingredient Identifier (UNII)</a>#2ZM8CX04RZ)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td>-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td>*</td><td>100 U/ml<span style="background: LightGoldenRodYellow"> (Details: UCUM code U/ml = 'U/ml')</span></td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.0.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="http://fdasis.nlm.nih.gov"/>
          <value value="2ZM8CX04RZ"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="ManufacturedItemDefinition/3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7"/>
        </for>
        <role>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="72072"/>
            <display value="active"/>
          </coding>
        </role>
        <manufacturer>
          <manufacturer>
            <reference value="Organization/9986b39a-e820-49a9-9b65-de34d6079331"/>
          </manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="http://fdasis.nlm.nih.gov"/>
                <code value="2ZM8CX04RZ"/>
                <display value="Insulin glargine"/>
              </coding>
            </concept>
          </code>
          <strength>
            <presentationQuantity>
              <value value="100"/>
              <system value="http://unitsofmeasure.org"/>
              <code value="U/ml"/>
            </presentationQuantity>
            <basis>
              <coding>
                <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
                <code value="ACTIB"/>
                <display value="active ingredient - basis of strength"/>
              </coding>
            </basis>
          </strength>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="Ingredient/34734d5b-c7cf-4a3e-bf87-1412db87476e"/>
    <resource>
      <Ingredient>
        <id value="34734d5b-c7cf-4a3e-bf87-1412db87476e"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Ingredient</b><a name="34734d5b-c7cf-4a3e-bf87-1412db87476e"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient &quot;34734d5b-c7cf-4a3e-bf87-1412db87476e&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id:Â 74O62BB01UÂ (use:Â OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href="#ManufacturedItemDefinition_3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7">See above (ManufacturedItemDefinition/3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7)</a></p><p><b>role</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#72072)</span></p><h3>Manufacturers</h3><table class="grid"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href="#Organization_9986b39a-e820-49a9-9b65-de34d6079331">See above (Organization/9986b39a-e820-49a9-9b65-de34d6079331)</a></td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td>-</td><td><b>Concept</b></td></tr><tr><td>*</td><td>Lixisenatide <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.0.0/CodeSystem-UNII.html">Unique Ingredient Identifier (UNII)</a>#74O62BB01U)</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td>-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td>*</td><td>50 ug/ml<span style="background: LightGoldenRodYellow"> (Details: UCUM code ug/ml = 'ug/ml')</span></td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.0.0/CodeSystem-v3-RoleClass.html">RoleClass</a>#ACTIB)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="http://fdasis.nlm.nih.gov"/>
          <value value="74O62BB01U"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="ManufacturedItemDefinition/3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7"/>
        </for>
        <role>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="72072"/>
            <display value="active"/>
          </coding>
        </role>
        <manufacturer>
          <manufacturer>
            <reference value="Organization/9986b39a-e820-49a9-9b65-de34d6079331"/>
          </manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="http://fdasis.nlm.nih.gov"/>
                <code value="74O62BB01U"/>
                <display value="Lixisenatide"/>
              </coding>
            </concept>
          </code>
          <strength>
            <presentationQuantity>
              <value value="50"/>
              <system value="http://unitsofmeasure.org"/>
              <code value="ug/ml"/>
            </presentationQuantity>
            <basis>
              <coding>
                <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
                <code value="ACTIB"/>
                <display value="active ingredient - basis of strength"/>
              </coding>
            </basis>
          </strength>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="Ingredient/06d11577-dc08-4fe4-b9f3-3b98f8e4159b"/>
    <resource>
      <Ingredient>
        <id value="06d11577-dc08-4fe4-b9f3-3b98f8e4159b"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Ingredient</b><a name="06d11577-dc08-4fe4-b9f3-3b98f8e4159b"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient &quot;06d11577-dc08-4fe4-b9f3-3b98f8e4159b&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-Ingredient-uv-epi.html">Ingredient (ePI)</a></p></div><p><b>identifier</b>: id:Â PDC6A3C0OXÂ (use:Â OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href="#ManufacturedItemDefinition_3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7">See above (ManufacturedItemDefinition/3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7)</a></p><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072082)</span></p><h3>Manufacturers</h3><table class="grid"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href="#Organization_9986b39a-e820-49a9-9b65-de34d6079331">See above (Organization/9986b39a-e820-49a9-9b65-de34d6079331)</a></td></tr></table><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td>-</td><td><b>Concept</b></td></tr><tr><td>*</td><td>Glycerol 85% <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.0.0/CodeSystem-UNII.html">Unique Ingredient Identifier (UNII)</a>#PDC6A3C0OX)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="http://fdasis.nlm.nih.gov"/>
          <value value="PDC6A3C0OX"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="ManufacturedItemDefinition/3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7"/>
        </for>
        <role>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
          <manufacturer>
            <reference value="Organization/9986b39a-e820-49a9-9b65-de34d6079331"/>
          </manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="http://fdasis.nlm.nih.gov"/>
                <code value="PDC6A3C0OX"/>
                <display value="Glycerol 85%"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="AdministrableProductDefinition/88272368-f0bf-4222-aec0-4829b44b6d0b"/>
    <resource>
      <AdministrableProductDefinition>
        <id value="88272368-f0bf-4222-aec0-4829b44b6d0b"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: AdministrableProductDefinition</b><a name="88272368-f0bf-4222-aec0-4829b44b6d0b"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource AdministrableProductDefinition &quot;88272368-f0bf-4222-aec0-4829b44b6d0b&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-AdministrableProductDefinition-uv-epi.html">AdministrableProductDefinition (ePI)</a></p></div><p><b>identifier</b>: id:Â TBD</p><p><b>status</b>: active</p><p><b>formOf</b>: <a href="#MedicinalProductDefinition_8e4f1fbf-70e9-470a-9694-e0168320b56c">See above (MedicinalProductDefinition/8e4f1fbf-70e9-470a-9694-e0168320b56c)</a></p><p><b>administrableDoseForm</b>: Solution for injection <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073863)</span></p><p><b>unitOfPresentation</b>: Pen <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002135)</span></p><p><b>producedFrom</b>: <a href="#ManufacturedItemDefinition_3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7">See above (ManufacturedItemDefinition/3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7)</a></p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Subcutaneous use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073633)</span></p><h3>TargetSpecies</h3><table class="grid"><tr><td>-</td><td><b>Code</b></td></tr><tr><td>*</td><td>Human <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000109093)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <system value="https://www.who-umc.org/phpid"/>
          <value value="TBD"/>
        </identifier>
        <status value="active"/>
        <formOf>
          <reference value="MedicinalProductDefinition/8e4f1fbf-70e9-470a-9694-e0168320b56c"/>
        </formOf>
        <administrableDoseForm>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000073863"/>
            <display value="Solution for injection"/>
          </coding>
        </administrableDoseForm>
        <unitOfPresentation>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="200000002135"/>
            <display value="Pen"/>
          </coding>
        </unitOfPresentation>
        <producedFrom>
          <reference value="ManufacturedItemDefinition/3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7"/>
        </producedFrom>
        <routeOfAdministration>
          <code>
            <coding>
              <system value="https://spor.ema.europa.eu/rmswi"/>
              <code value="100000073633"/>
              <display value="Subcutaneous use"/>
            </coding>
          </code>
          <targetSpecies>
            <code>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi"/>
                <code value="100000109093"/>
                <display value="Human"/>
              </coding>
            </code>
          </targetSpecies>
        </routeOfAdministration>
      </AdministrableProductDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="RegulatedAuthorization/36aab683-567b-42c5-a65c-b3c2749b4660"/>
    <resource>
      <RegulatedAuthorization>
        <id value="36aab683-567b-42c5-a65c-b3c2749b4660"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: RegulatedAuthorization</b><a name="36aab683-567b-42c5-a65c-b3c2749b4660"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource RegulatedAuthorization &quot;36aab683-567b-42c5-a65c-b3c2749b4660&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-RegulatedAuthorization-uv-epi.html">RegulatedAuthorization (ePI)</a></p></div><p><b>identifier</b>: id:Â EU/1/16/1157/002Â (use:Â OFFICIAL)</p><p><b>subject</b>: <a href="#MedicinalProductDefinition_8e4f1fbf-70e9-470a-9694-e0168320b56c">See above (MedicinalProductDefinition/8e4f1fbf-70e9-470a-9694-e0168320b56c)</a></p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072062)</span></p><p><b>region</b>: Denmark <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.0.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions â Part 1: Country code</a>#DK)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/5.0.0-snapshot3/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2017-01-11 13:28:17+0000</p><p><b>holder</b>: <a href="#Organization_9986b39a-e820-49a9-9b65-de34d6079331">See above (Organization/9986b39a-e820-49a9-9b65-de34d6079331)</a></p></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/pmswi"/>
          <value value="EU/1/16/1157/002"/>
        </identifier>
        <subject>
          <reference value="MedicinalProductDefinition/8e4f1fbf-70e9-470a-9694-e0168320b56c"/>
        </subject>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072062"/>
            <display value="Marketing Authorisation"/>
          </coding>
        </type>
        <region>
          <coding>
            <system value="urn:iso:std:iso:3166"/>
            <code value="DK"/>
            <display value="Denmark"/>
          </coding>
        </region>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status"/>
            <code value="active"/>
            <display value="Active"/>
          </coding>
        </status>
        <statusDate value="2017-01-11T13:28:17Z"/>
        <holder>
          <reference value="Organization/9986b39a-e820-49a9-9b65-de34d6079331"/>
        </holder>
      </RegulatedAuthorization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="Organization/9986b39a-e820-49a9-9b65-de34d6079331"/>
    <resource>
      <Organization>
        <id value="9986b39a-e820-49a9-9b65-de34d6079331"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Organization</b><a name="9986b39a-e820-49a9-9b65-de34d6079331"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Organization &quot;9986b39a-e820-49a9-9b65-de34d6079331&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-Organization-uv-epi.html">Organization (ePI)</a></p></div><p><b>identifier</b>: id:Â ORG-100000789Â (use:Â OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000034)</span></p><p><b>name</b>: Sanofi-Aventis Groupe</p><h3>Contacts</h3><table class="grid"><tr><td>-</td><td><b>Address</b></td></tr><tr><td>*</td><td>54, rue La BoeÌtie F-75008 Paris FR(WORK)</td></tr></table></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/omswi"/>
          <value value="ORG-100000789"/>
        </identifier>
        <active value="true"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="220000000034"/>
            <display value="Marketing authorisation holder"/>
          </coding>
          <text value="Marketing authorisation holder"/>
        </type>
        <name value="Sanofi-Aventis Groupe"/>
        <contact>
          <address>
            <use value="work"/>
            <type value="physical"/>
            <text value="54, rue La BoeÌtie F-75008 Paris FR"/>
            <line value="54, rue La BoeÌtie F-75008"/>
            <city value="Paris"/>
            <country value="FR"/>
          </address>
        </contact>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="Organization/a86857b5-0210-4df3-b550-e326ab3e2101"/>
    <resource>
      <Organization>
        <id value="a86857b5-0210-4df3-b550-e326ab3e2101"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Organization</b><a name="a86857b5-0210-4df3-b550-e326ab3e2101"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Organization &quot;a86857b5-0210-4df3-b550-e326ab3e2101&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-Organization-uv-epi.html">Organization (ePI)</a></p></div><p><b>identifier</b>: id:Â ORG-100001175Â (use:Â OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Manufacturer API <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000033)</span></p><p><b>name</b>: Sanofi-Aventis Deutschland GmbH</p><h3>Contacts</h3><table class="grid"><tr><td>-</td><td><b>Address</b></td></tr><tr><td>*</td><td>Brueningstrasse 50, Industriepark HÃ¶chst Frankfurt am Main de(WORK)</td></tr></table></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/omswi"/>
          <value value="ORG-100001175"/>
        </identifier>
        <active value="true"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="220000000033"/>
            <display value="Manufacturer API"/>
          </coding>
          <text value="Manufacturer API"/>
        </type>
        <name value="Sanofi-Aventis Deutschland GmbH"/>
        <contact>
          <address>
            <use value="work"/>
            <type value="physical"/>
            <text value="Brueningstrasse 50, Industriepark HÃ¶chst Frankfurt am Main de"/>
            <line value="Brueningstrasse 50, Industriepark HÃ¶chst"/>
            <city value="Frankfurt am Main"/>
            <postalCode value="65926"/>
            <country value="de"/>
          </address>
        </contact>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="Organization/6f34afc3-66a7-4410-99ad-53604ea211f4"/>
    <resource>
      <Organization>
        <id value="6f34afc3-66a7-4410-99ad-53604ea211f4"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Organization</b><a name="6f34afc3-66a7-4410-99ad-53604ea211f4"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Organization &quot;6f34afc3-66a7-4410-99ad-53604ea211f4&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-Organization-uv-epi.html">Organization (ePI)</a></p></div><p><b>identifier</b>: id:Â ORG-100001175Â (use:Â OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Manufacturer Batch release <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000033)</span></p><p><b>name</b>: Sanofi-Aventis Deutschland GmbH</p><h3>Contacts</h3><table class="grid"><tr><td>-</td><td><b>Address</b></td></tr><tr><td>*</td><td>Brueningstrasse 50, Industriepark HÃ¶chst Frankfurt am Main de(WORK)</td></tr></table></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/omswi"/>
          <value value="ORG-100001175"/>
        </identifier>
        <active value="true"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="220000000033"/>
            <display value="Manufacturer Batch release"/>
          </coding>
          <text value="Manufacturer Batch release"/>
        </type>
        <name value="Sanofi-Aventis Deutschland GmbH"/>
        <contact>
          <address>
            <use value="work"/>
            <type value="physical"/>
            <text value="Brueningstrasse 50, Industriepark HÃ¶chst Frankfurt am Main de"/>
            <line value="Brueningstrasse 50, Industriepark HÃ¶chst"/>
            <city value="Frankfurt am Main"/>
            <postalCode value="65927"/>
            <country value="de"/>
          </address>
        </contact>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="Organization/dbeccd59-b7ba-4640-a617-ad9d910e71bf"/>
    <resource>
      <Organization>
        <id value="dbeccd59-b7ba-4640-a617-ad9d910e71bf"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Organization</b><a name="dbeccd59-b7ba-4640-a617-ad9d910e71bf"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Organization &quot;dbeccd59-b7ba-4640-a617-ad9d910e71bf&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-Organization-uv-epi.html">Organization (ePI)</a></p></div><p><b>identifier</b>: id:Â ORG-100013412Â (use:Â OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Medicines Regulatory Authority <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#220000000033)</span></p><p><b>name</b>: European Medicines Agency</p><h3>Contacts</h3><table class="grid"><tr><td>-</td><td><b>Address</b></td></tr><tr><td>*</td><td>Carretera De Martorell 41 61, Poligono Industrial Nord-Est Amsterdam nl(WORK)</td></tr></table></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/omswi"/>
          <value value="ORG-100013412"/>
        </identifier>
        <active value="true"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="220000000033"/>
            <display value="Medicines Regulatory Authority"/>
          </coding>
          <text value="Medicines Regulatory Authority"/>
        </type>
        <name value="European Medicines Agency"/>
        <contact>
          <address>
            <use value="work"/>
            <type value="physical"/>
            <text value="Carretera De Martorell 41 61, Poligono Industrial Nord-Est Amsterdam nl"/>
            <line value="Carretera De Martorell 41 61, Poligono Industrial Nord-Est"/>
            <city value="Amsterdam"/>
            <postalCode value="1083 HS"/>
            <country value="nl"/>
          </address>
        </contact>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="PackagedProductDefinition/560639ae-8c6a-4f98-9a5b-455534b1b16a"/>
    <resource>
      <PackagedProductDefinition>
        <id value="560639ae-8c6a-4f98-9a5b-455534b1b16a"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: PackagedProductDefinition</b><a name="560639ae-8c6a-4f98-9a5b-455534b1b16a"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource PackagedProductDefinition &quot;560639ae-8c6a-4f98-9a5b-455534b1b16a&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-PackagedProductDefinition-uv-epi.html">PackagedProductDefinition (ePI)</a></p></div><p><b>identifier</b>: id:Â EU/1/16/1157/002Â (use:Â OFFICIAL)</p><p><b>name</b>: adalimumab</p><p><b>type</b>: Chemical Medicinal Prodcut <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000155527)</span></p><p><b>packageFor</b>: <a href="#MedicinalProductDefinition_8e4f1fbf-70e9-470a-9694-e0168320b56c">See above (MedicinalProductDefinition/8e4f1fbf-70e9-470a-9694-e0168320b56c)</a></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/5.0.0-snapshot3/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2015-02-07 13:28:17+0000</p><p><b>containedItemQuantity</b>: 3 ml<span style="background: LightGoldenRodYellow"> (Details: UCUM code ml = 'ml')</span></p><p><b>description</b>: Type I colourless glass cartridge with a black plunger (bromobutyl rubber) and a flanged cap (aluminium) with inserted laminated sealing disks (bromobutyl rubber on the medicinal product side and polyisoprene on the outside) containing 3 ml of solution. Each cartridge is assembled into a disposable pen.</p><p><b>copackagedIndicator</b>: false</p><p><b>manufacturer</b>: <a href="#Organization_9986b39a-e820-49a9-9b65-de34d6079331">See above (Organization/9986b39a-e820-49a9-9b65-de34d6079331)</a></p><h3>Packagings</h3><table class="grid"><tr><td>-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td>*</td><td>id:Â EU/1/16/1157/002</td><td>Pre-filled pen <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000073543)</span></td><td>5</td><td>Glass type 1 <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000003204)</span></td></tr></table></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/pmswi"/>
          <value value="EU/1/16/1157/002"/>
        </identifier>
        <name value="adalimumab"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000155527"/>
            <display value="Chemical Medicinal Prodcut"/>
          </coding>
        </type>
        <packageFor>
          <reference value="MedicinalProductDefinition/8e4f1fbf-70e9-470a-9694-e0168320b56c"/>
        </packageFor>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status"/>
            <code value="active"/>
            <display value="Active"/>
          </coding>
        </status>
        <statusDate value="2015-02-07T13:28:17Z"/>
        <containedItemQuantity>
          <value value="3"/>
          <system value="http://unitsofmeasure.org"/>
          <code value="ml"/>
        </containedItemQuantity>
        <description value="Type I colourless glass cartridge with a black plunger (bromobutyl rubber) and a flanged cap (aluminium) with inserted laminated sealing disks (bromobutyl rubber on the medicinal product side and polyisoprene on the outside) containing 3 ml of solution. Each cartridge is assembled into a disposable pen."/>
        <copackagedIndicator value="false"/>
        <manufacturer>
          <reference value="Organization/9986b39a-e820-49a9-9b65-de34d6079331"/>
        </manufacturer>
        <packaging>
          <identifier>
            <system value="https://spor.ema.europa.eu/pmswi"/>
            <value value="EU/1/16/1157/002"/>
          </identifier>
          <type>
            <coding>
              <system value="https://spor.ema.europa.eu/rmswi"/>
              <code value="100000073543"/>
              <display value="Pre-filled pen"/>
            </coding>
          </type>
          <quantity value="5"/>
          <material>
            <coding>
              <system value="https://spor.ema.europa.eu/rmswi"/>
              <code value="200000003204"/>
              <display value="Glass type 1"/>
            </coding>
          </material>
        </packaging>
      </PackagedProductDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="MedicinalProductDefinition/8e4f1fbf-70e9-470a-9694-e0168320b56c"/>
    <resource>
      <MedicinalProductDefinition>
        <id value="8e4f1fbf-70e9-470a-9694-e0168320b56c"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicinalProductDefinition</b><a name="8e4f1fbf-70e9-470a-9694-e0168320b56c"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicinalProductDefinition &quot;8e4f1fbf-70e9-470a-9694-e0168320b56c&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-MedicinalProductDefinition-uv-epi.html">MedicinalProductDefinition (ePI)</a></p></div><p><b>identifier</b>: id:Â EU/1/16/1157/002</p><p><b>type</b>: Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/5.0.0-snapshot3/codesystem-medicinal-product-type.html">MedicinalProductType</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/5.0.0-snapshot3/codesystem-medicinal-product-domain.html">MedicinalProductDomain</a>#Human)</span></p><p><b>status</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/5.0.0-snapshot3/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>indication</b>: Suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without SGLT-2 inhibitors.</p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#100000072084)</span></p><p><b>classification</b>: insulin glargine and lixisenatide <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.0.0/CodeSystem-v3-WC.html">WHO ATC</a>#A10AE54)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: adalimumab</p><p><b>type</b>: Full name <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000001)</span></p><blockquote><p><b>part</b></p><p><b>part</b>: Suliqua</p><p><b>type</b>: Invented name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000002)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Insulin glargine, Lixisenatide</p><p><b>type</b>: Scientific name part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000003)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 100 units/ml + 50 ug/ml</p><p><b>type</b>: Strength part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000004)</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: Solution for injection</p><p><b>type</b>: Pharmaceutical dose form part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (220000000000#220000000005)</span></p></blockquote><h3>Usages</h3><table class="grid"><tr><td>-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td>*</td><td>Denmark <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.0.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions â Part 1: Country code</a>#DK)</span></td><td>Denmark <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.0.0/CodeSystem-ISO3166Part1.html">ISO 3166-1 Codes for the representation of names of countries and their subdivisions â Part 1: Country code</a>#DK)</span></td><td>English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.0.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#en)</span></td></tr></table></blockquote></div>
        </text>
        <identifier>
          <system value="https://spor.ema.europa.eu/pmswi"/>
          <value value="EU/1/16/1157/002"/>
        </identifier>
        <type>
          <coding>
            <system value="http://hl7.org/fhir/medicinal-product-type"/>
            <code value="MedicinalProduct"/>
            <display value="Medicinal Product"/>
          </coding>
        </type>
        <domain>
          <coding>
            <system value="http://hl7.org/fhir/medicinal-product-domain"/>
            <code value="Human"/>
            <display value="Human use"/>
          </coding>
        </domain>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status"/>
            <code value="active"/>
            <display value="active"/>
          </coding>
        </status>
        <indication value="Suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without SGLT-2 inhibitors."/>
        <legalStatusOfSupply>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="100000072084"/>
            <display value="Medicinal product subject to medical prescription"/>
          </coding>
        </legalStatusOfSupply>
        <classification>
          <coding>
            <system value="http://www.whocc.no/atc"/>
            <code value="A10AE54"/>
            <display value="insulin glargine and lixisenatide"/>
          </coding>
        </classification>
        <name>
          <productName value="adalimumab"/>
          <type>
            <coding>
              <system value="https://spor.ema.europa.eu/rmswi/220000000000"/>
              <code value="220000000001"/>
            </coding>
            <text value="Full name"/>
          </type>
          <part>
            <part value="Suliqua"/>
            <type>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi/220000000000"/>
                <code value="220000000002"/>
              </coding>
              <text value="Invented name part"/>
            </type>
          </part>
          <part>
            <part value="Insulin glargine, Lixisenatide"/>
            <type>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi/220000000000"/>
                <code value="220000000003"/>
              </coding>
              <text value="Scientific name part"/>
            </type>
          </part>
          <part>
            <part value="100 units/ml + 50 ug/ml"/>
            <type>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi/220000000000"/>
                <code value="220000000004"/>
              </coding>
              <text value="Strength part"/>
            </type>
          </part>
          <part>
            <part value="Solution for injection"/>
            <type>
              <coding>
                <system value="https://spor.ema.europa.eu/rmswi/220000000000"/>
                <code value="220000000005"/>
              </coding>
              <text value="Pharmaceutical dose form part"/>
            </type>
          </part>
          <usage>
            <country>
              <coding>
                <system value="urn:iso:std:iso:3166"/>
                <code value="DK"/>
                <display value="Denmark"/>
              </coding>
            </country>
            <jurisdiction>
              <coding>
                <system value="urn:iso:std:iso:3166"/>
                <code value="DK"/>
                <display value="Denmark"/>
              </coding>
            </jurisdiction>
            <language>
              <coding>
                <system value="urn:ietf:bcp:47"/>
                <code value="en"/>
                <display value="English"/>
              </coding>
            </language>
          </usage>
        </name>
      </MedicinalProductDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="ManufacturedItemDefinition/3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7"/>
    <resource>
      <ManufacturedItemDefinition>
        <id value="3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"/>
        </meta>
        <text>
          <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: ManufacturedItemDefinition</b><a name="3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ManufacturedItemDefinition &quot;3cc3914b-e0f5-43f4-b4fc-c02e7c70ecf7&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ManufacturedItemDefinition-uv-epi.html">ManufacturedItemDefinition (ePI)</a></p></div><p><b>identifier</b>: id:Â EU/1/16/1157/003Â (use:Â OFFICIAL)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Solution <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#200000002007)</span></p><p><b>unitOfPresentation</b>: Pen <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (rmswi#200000002135)</span></p><p><b>manufacturer</b>: <a href="#Organization_9986b39a-e820-49a9-9b65-de34d6079331">See above (Organization/9986b39a-e820-49a9-9b65-de34d6079331)</a></p></div>
        </text>
        <identifier>
          <use value="official"/>
          <system value="https://spor.ema.europa.eu/pmswi/#/"/>
          <value value="EU/1/16/1157/003"/>
        </identifier>
        <status value="active"/>
        <manufacturedDoseForm>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi/"/>
            <code value="200000002007"/>
            <display value="Solution"/>
          </coding>
        </manufacturedDoseForm>
        <unitOfPresentation>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="200000002135"/>
            <display value="Pen"/>
          </coding>
        </unitOfPresentation>
        <manufacturer>
          <reference value="Organization/9986b39a-e820-49a9-9b65-de34d6079331"/>
        </manufacturer>
      </ManufacturedItemDefinition>
    </resource>
  </entry>
</Bundle>